Denali Therapeutics denalitherapeutics.com


Public lists: Pharma Startups (4734)

Denali Therapeutics is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative disease, including Alzheimer's disease, Parkinson's disease, ALS and others.

Denali Therapeutics is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative disease, including Alzheimer's disease, Parkinson's disease, ALS and others.

Company (IPO / Went public)

Phone:

Fax:

151 Oyster Point Blvd

South San Francisco, 94080
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Denali Therapeutics $597M Dec 8, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Denali Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Compounds, compositions, and methods Oct 25, 2017 Apr 03, 2018 Patent
Compounds, compositions and methods Sep 29, 2017 Feb 20, 2018 Patent
Compounds, compositions and methods Feb 03, 2017 Nov 14, 2017 Patent
Oxadiazine compounds and methods of use thereof Jun 10, 2016 Oct 31, 2017 Patent
Fused morpholinopyrimidines and methods of use thereof Jul 15, 2016 Sep 26, 2017 Patent
See all 7 patents